A pharmacist's quick check on inhaler costs and guidelines may keep COPD and asthma patients out of the hospital

This trial tests whether a pharmacist, at the time of hospital admission, can review a patient's prescribed inhaler for insurance coverage and clinical appropriateness. The goal is to see if this simple check helps patients get the most cost-effective inhaler and reduces the chance of being readmitted or visiting the emergency department within six months. The study includes adults with COPD or asthma who are already on or prescribed a long-acting inhaler.